Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Mut Salud, Nuria ^a   Álvarez, Pablo Juan ^a   Garrido, Jose Manuel ^b   Carrasco, Esther ^a   Aránega, Antonia ^a   Rodríguez Serrano, Fernando ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DISEASES; NUTRITION;

ANTI-TUMORS; ANTITUMOR DRUGS; HEALTHY TISSUES; ITS EFFICIENCIES; MECHANISM OF ACTION; NATURAL SOURCES; NUTRITIONAL SUPPLEMENTS; OPTIMAL RESULTS;

ANTIOXIDANTS;

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAFFEIC ACID DERIVATIVE; CAROTENOID; CHLOROGENIC ACID; DAIDZEIN; FERULIC ACID; FLAVONOID; GENISTEIN; HESPERETIN; LYCOPENE; MELATONIN; POLYPHENOL; PROANTHOCYANIDIN; QUERCETIN; RESVERATROL; SELENIUM; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; VITAMIN K GROUP;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER THERAPY; CELL PROTECTION; COFFEE; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA DAMAGE; DRUG MECHANISM; HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; LONG TERM CARE; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; REVIEW; TEA; VEGETABLE; ANIMAL; DIET THERAPY; NUTRITION POLICY;

ANIMALS; ANTIOXIDANTS; HUMANS; NEOPLASMS; NUTRITION POLICY;

EID: 84949266522     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/6719534     Document Type: Review

References (212)

1. B. Halliwell, J. M. C. Gutteridge, and C. E. Cross, "Free radicals, antioxidants, and human disease: where are we now" The Journal of Laboratory and Clinical Medicine, vol. 119, no. 6, pp. 598-620, 1992.
2. B. Halliwell and J. M. C. Gutteridge, "The antioxidants of human extracellular fluids,"Archives of Biochemistry and Biophysics, vol. 280, no. 1, pp. 1-8, 1990.
3. A. I. Khlebnikov, I. A. Schepetkin, N. G. Domina, L. N. Kirpotina, and M. T. Quinn, "Improved quantitative structureactivity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems," Bioorganic and Medicinal Chemistry, vol. 15, no. 4, pp. 1749-1770, 2007.
4. L. A. Pham-Huy, H. He, and C. Pham-Huy, "Free radicals, antioxidants in disease and health," International Journal of Biomedical Science, vol. 4, no. 2, pp. 89-96, 2008.
5. M. Fransen, M. Nordgren, B. Wang, andO. Apanasets, "Role of peroxisomes in ROS/RNS-metabolism: implications for human disease," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1822, no. 9, pp. 1363-1373, 2012.
6. F. J. Corpas and J. B. Barroso, "Reactive sulfur species (RSS): possible new players in the oxidative metabolism of plant peroxisomes," Frontiers in Plant Science, vol. 6, article 116, 2015.
7. S. Hekimi, J. Lapointe, and Y. Wen, "Taking a 'good' look at free radicals in the aging process," Trends in Cell Biology, vol. 21, no. 10, pp. 569-576, 2011.
8. H. Kawagishi and T. Finkel, "Unraveling the truth about antioxidants: ROS and disease: finding the right balance," Nature Medicine, vol. 20, no. 7, pp. 711-713, 2014.
9. A. Popa-Wagner, S. Mitran, S. Sivanesan, E. Chang, and A.-M. Buga, "ROS and brain diseases: the good, the bad, and the ugly," Oxidative Medicine and Cellular Longevity, vol. 2013,Article ID 963520, 14 pages, 2013.
10. B. Zhao, "Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease," Neurochemical Research, vol. 34, no. 4, pp. 630-638, 2009.
11. A. S. Watson, M. Mortensen, and A. K. Simon, "Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia," Cell Cycle, vol. 10, no. 11, pp. 1719-1725, 2011.
12. J. M. Matés, C. Pérez-Gómez, and I. N. de Castro, "Antioxidant enzymes and human diseases," Clinical Biochemistry, vol. 32,no. 8, pp. 595-603, 1999.
13. Y.-Z. Fang, S. Yang, and G. Wu, "Free radicals, antioxidants, and nutrition," Nutrition, vol. 18, no. 10, pp. 872-879, 2002.
14. M. Goodman,R. M. Bostick,O. Kucuk, andD. P. Jones, "Clinical trials of antioxidants as cancer prevention agents: past, present, and future," Free Radical Biology andMedicine, vol. 51, no. 5, pp. 1068-1084, 2011.
15. N. Ito, S. Fukushima, and H. Tsuda, "Carcinogenicity and modification of the carcinogenic response by bha, bht, and other antioxidants," Critical Reviews in Toxicology, vol. 15, no. 2, pp. 109-150, 1985.
16. R. Kahl andH. Kappus, "Toxikologie der synthetischenAntioxidantien BHA und BHT im Vergleich mit dem natürlichen Antioxidans Vitamin E," Zeitschrift für Lebensmittel-Untersuchung und Forschung, vol. 196, no. 4, pp. 329-338, 1993.
17. A. A. M. Botterweck, H. Verhagen, R. A. Goldbohm, J. Kleinjans, and P. A. van den Brandt, "Intake of butylated hydroxyanisole and butylated hydroxytoluene and stomach cancer risk: results from analyses in the Netherlands Cohort Study," Food and Chemical Toxicology, vol. 38, no. 7, pp. 599-605, 2000.
18. M. Carocho and I. C. F. R. Ferreira, "A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives," Food and Chemical Toxicology, vol. 51, no. 1, pp. 15-25, 2013.
19. A. Shetti, V. Keluskar, and A. Aggarwal, "Antioxidants: enhancing oral and general health," Journal of Indian Academy of Oral Medicine and Radiology, vol. 21, no. 1, pp. 1-6, 2009.
20. M. Irshad and P. S. Chaudhuri, "Oxidant-antioxidant system: role and significance in human body," Indian Journal of Experimental Biology, vol. 40, no. 11, pp. 1233-1239, 2002.
21. V. Sindhi, V. Gupta, K. Sharma, S. Bhatnagar, R. Kumari, and N. Dhaka, "Potential applications of antioxidants-a review," Journal of Pharmacy Research, vol. 7, no. 9, pp. 828-835, 2013.
22. H. El Gharras, "Polyphenols: food sources, properties and applications-a review," International Journal of Food Science and Technology, vol. 44, no. 12, pp. 2512-2518, 2009.
23. J. M. Landete, "Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health," Critical Reviews in Food Science and Nutrition, vol. 52, no. 10, pp. 936-948, 2012.
24. C. Guerra-Araiza, A. L. Alvarez-Mejá, S. Sánchez-Torres et al., "Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases," Free Radical Research, vol. 47, no. 6-7, pp. 451-462, 2013.
25. S. Quideau, D. Deffieux, C. Douat-Casassus, and L. Pouységu, "Plant polyphenols: chemical properties, biological activities, and synthesis," Angewandte Chemie-International Edition, vol. 50, no. 3, pp. 586-621, 2011.
26. B. A. Graf, P. E. Milbury, and J. B. Blumberg, "Flavonols, flavones, flavanones, and human health: epidemiological evidence," Journal of Medicinal Food, vol. 8, no. 3, pp. 281-290, 2005.
27. D. D. Orhan, B. Özçelik, S. Özgen, and F. Ergun, "Antibacterial, antifungal, and antiviral activities of some flavonoids," Microbiological Research, vol. 165, no. 6, pp. 496-504, 2010.
28. G. Agati, E. Azzarello, S. Pollastri, and M. Tattini, "Flavonoids as antioxidants in plants: location and functional significance," Plant Science, vol. 196, pp. 67-76, 2012.
29. L. L. Bennett, S. Rojas, and T. Seefeldt, "Role of antioxidants in the prevention of cancer," Journal of Experimental and Clinical Medicine, vol. 4, no. 4, pp. 215-222, 2012.
30. L. Pérez-Rodrguez, F. Mougeot, and C. Alonso-Alvarez, "Carotenoid-based coloration predicts resistance to oxidative damage during immune challenge," Journal of Experimental Biology, vol. 213, no. 10, pp. 1685-1690, 2010.
31. A. V. Rao and L. G. Rao, "Carotenoids and human health," Pharmacological Research, vol. 55, no. 3, pp. 207-216, 2007.
32. A. I. R. N. A. Barros, F. M. Nunes, B. Gonalves, R. N. Bennett, and A. P. Silva, "Effect of cooking on total vitamin C contents and antioxidant activity of sweet chestnuts (Castanea sativa Mill. )," Food Chemistry, vol. 128, no. 1, pp. 165-172, 2011.
33. M. G. Traber and J. F. Stevens, "Vitamins C and E: beneficial effects fromamechanistic perspective," Free Radical Biology and Medicine, vol. 51, no. 5, pp. 1000-1013, 2011.
34. M. Giammanco, D. D. Majo, G. Leto, C. Flandina, M. D. Piazza, and M. L. Guardia, "The role of vitamin k in bone remodeling and osteoporosis," Journal of Food Research, vol. 1, no. 4, article 106, 2012.
35. I. M. Puspitasari, R. Abdulah, C. Yamazaki, S. Kameo, T. Nakano, and H. Koyama, "Updates on clinical studies of selenium supplementation in radiotherapy," Radiation Oncology, vol. 9, no. 1, article 125, 2014.
36. A. S. Prasad, "Zinc: An antioxidant and anti-inflammatory agent: role of zinc in degenerative disorders of aging," Journal of Trace Elements in Medicine and Biology, vol. 28, no. 4, pp. 364-371, 2014.
37. A. Formigari, P. Irato, andA. Santon, "Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects," Comparative Biochemistry and Physiology Part C Toxicology and Pharmacology, vol. 146, no. 4, pp. 443-459, 2007.
38. A. Formigari, E. Gregianin, and P. Irato, "The effect of zinc and the role of p53 in copper-induced cellular stress responses," Journal of Applied Toxicology, vol. 33, no. 7, pp. 527-536, 2013.
39. Vijayalaxmi, C. R. Thomas Jr., R. J. Reiter, and T. S. Herman, "Melatonin: from basic research to cancer treatment clinics," Journal of Clinical Oncology, vol. 20, no. 10, pp. 2575-2601, 2002.
40. G. F. Rushworth and I. L. Megson, "Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits," Pharmacology andTherapeutics, vol. 141, no. 2, pp. 150-159, 2014.
41. M. H. Carlsen, B. L. Halvorsen, K. Holte et al., "The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide," Nutrition Journal, vol. 9, no. 1, article 3, 2010.
42. F. Cattaneo, J. E. Sayago,M. R. Alberto et al., "Anti-inflammatory and antioxidant activities, functional properties andmutagenicity studies of protein and protein hydrolysate obtained fromProsopis alba seed flour," Food Chemistry, vol. 161, pp. 391-399, 2014.
43. C. F. Oliveira, D. Coletto, A. P. F. Correa et al., "Antioxidant activity and inhibition of meat lipid oxidation by soy protein hydrolysates obtained with a microbial protease," International Food Research Journal, vol. 21, no. 2, pp. 775-781, 2014.
44. O. Vang, N. Ahmad, C. A. Baile et al., "What is new for an old molecule? systematic review and recommendations on the use of resveratrol," PLoS ONE, vol. 6, no. 6,Article ID e19881, 2011.
45. T. M. Rains, S. Agarwal, and K. C. Maki, "Antiobesity effects of green tea catechins: Amechanistic review," Journal of Nutritional Biochemistry, vol. 22, no. 1, pp. 1-7, 2011.
46. F. Thielecke and M. Boschmann, "The potential role of green tea catechins in the prevention of the metabolic syndrome-a review," Phytochemistry, vol. 70, no. 1, pp. 11-24, 2009.
47. V. Nandakumar, T. Singh, andS. K. Katiyar, "Multi-targetedprevention and therapy of cancer by proanthocyanidins," Cancer Letters, vol. 269, no. 2, pp. 378-387, 2008.
48. A. W. Boots, G. R. M. M. Haenen, and A. Bast, "Health effects of quercetin: from antioxidant to nutraceutical," European Journal of Pharmacology, vol. 585, no. 2-3, pp. 325-337, 2008.
49. C. Spagnuolo, M. Russo, S. Bilotto, I. Tedesco, B. Laratta, and G. L. Russo, "Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia," Annals of the New York Academy of Sciences, vol. 1259, no. 1, pp. 95-103, 2012.
50. Z.-R. Huang, C.-F. Hung, Y.-K. Lin, and J.-Y. Fang, "In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein," International Journal of Pharmaceutics, vol. 364, no. 1, pp. 36-44, 2008.
51. E. J. Choi, "Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice," Life Sciences, vol. 82, no. 21-22, pp. 1059-1064, 2008.
52. Y. Sato, S. Itagaki, T. Kurokawa et al., "In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid," International Journal of Pharmaceutics, vol. 403, no. 1-2,pp. 136-138, 2011.
53. Z. Zhao and M. H. Moghadasian, "Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: A review," Food Chemistry, vol. 109, no. 4, pp. 691-702, 2008.
54. J. P. E. Spencer, M. M. Abd El Mohsen, A.-M. Minihane, and J. C. Mathers, "Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research," British Journal of Nutrition, vol. 99, no. 1, pp. 12-22, 2008.
55. A. Scalbert, C. Manach,C. Morand, C. Rémésy, and L. Jiménez, "Dietary polyphenols and the prevention of diseases," Critical Reviews in Food Science and Nutrition, vol. 45, no. 4, pp. 287-306, 2005.
56. M. Bubonja-Sonje, J. Giacometti, and M. Abram, "Antioxidant and antilisterial activity of olive oil, cocoa and rosemary extract polyphenols," Food Chemistry, vol. 127, no. 4, pp. 1821-1827, 2011.
57. M. Calatayud, C. López-De-Dicastillo, G. López-Carballo, D. Vélez, P. HernándezMuñoz, and R. Gavara, "Active films based on cocoa extract with antioxidant, antimicrobial and biological applications," Food Chemistry, vol. 139, no. 1-4, pp. 51-58, 2013.
58. D. L. Katz, K. Doughty, and A. Ali, "Cocoa and chocolate in human health and disease," Antioxidants and Redox Signaling, vol. 15, no. 10, pp. 2779-2811, 2011.
59. D. Rossi, A. Guerrini, S. Maietti et al., "Chemical fingerprinting and bioactivity of Amazonian Ecuador Croton lechleri Müll. Arg. (Euphorbiaceae) stem bark essential oil: A new functional food ingredient" Food Chemistry, vol. 126, no. 3, pp. 837-848, 2011.
60. A. J. Alonso-Castro, E. Ortiz-Sánchez, F. Domnguez et al., "Antitumor effect of Croton lechleri Mull. Arg. (Euphorbiaceae)," Journal of Ethnopharmacology, vol. 140, no. 2,pp. 438-442, 2012.
61. N. Kumari, P. Kumar, D. Mitra, B. Prasad, B. N. Tiwary, and L. Varshney, "Effects of ionizing radiation on microbial decontamination, phenolic contents, and antioxidant properties of Triphala," Journal of Food Science, vol. 74, no. 3, pp. M109-M113, 2009.
62. A. Shehzad, J. Lee, and Y. S. Lee, "Curcumin in various cancers," BioFactors, vol. 39, no. 1, pp. 56-68, 2013.
63. M. Salem, S. Rohani, and E. R. Gillies, "Curcumin, a promising anti-cancer therapeutic: A review of its chemical properties, bioactivity and approaches to cancer cell delivery," RSC Advances, vol. 4, no. 21, pp. 10815-10829, 2014.
64. S. S. Boyanapalli and A. T. Kong, "'Curcumin, the king of spices': epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases," Current Pharmacology Reports, vol. 1, no. 2, pp. 129-139, 2015.
65. L. H. Kushi, C. Doyle, M. McCullough et al., "American Cancer Society guidelines on nutrition and physical activity for cancer prevention," CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 30-67, 2012.
66. Y.-J. Surh, "Nrf2, an essential component of cellular stress response, as a potential target of hormetic phytochemicals," Journal of Food and Drug Analysis, vol. 20, no. 1, pp. 217-219, 2012.
67. B. Bozin, N. Mimica-Dukic, I. Samojlik, and E. Jovin, "Antimicrobial and antioxidant properties of Rosemary and Sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils," Journal of Agricultural and Food Chemistry, vol. 55, no. 19, pp. 7879-7885, 2007.
68. M. M. Özcan and D. Arslan, "Antioxidant effect of essential oils of rosemary, clove and cinnamon on hazelnut and poppy oils," Food Chemistry, vol. 129, no. 1, pp. 171-174, 2011.
69. D. Krishnaiah, R. Sarbatly, and R. Nithyanandam, "A review of the antioxidant potential of medicinal plant species," Food and Bioproducts Processing, vol. 89, no. 3, pp. 217-233, 2011.
70. R. Estruch, E. Ros, J. Salas-Salvadó et al., "Primary prevention of cardiovascular disease with a Mediterranean diet," The New England Journal of Medicine, vol. 368, no. 14, pp. 1279-1290, 2013.
71. E. H. Martinez-Lapiscina, P. Clavero, E. Toledo et al., "Virgin olive oil supplementation and long-term cognition: the Predimed-Navarra randomized, trial," Journal of Nutrition, Health and Aging, vol. 17, no. 6, pp. 544-552, 2013.
72. A. Hartmann, C.-D. Patz, W. Andlauer, H. Dietrich, and M. Ludwig, "Influence of processing on quality parameters of strawberries," Journal of Agricultural and Food Chemistry, vol. 56, no. 20, pp. 9484-9489, 2008.
73. J. Dai and R. J. Mumper, "Plant phenolics: extraction, analysis and their antioxidant and anticancer properties,"Molecules, vol. 15, no. 10, pp. 7313-7352, 2010.
74. D. G. Lindsay and S. B. Astley, "European research on the functional effects of dietary antioxidants-EUROFEDA," Molecular Aspects of Medicine, vol. 23, no. 1-3, pp. 1-38, 2002.
75. N. Z. Unlu, T. Bohn, D. M. Francis, H. Nagaraja, S. K. Clinton, and S. J. Schwartz, "Lycopene from heat-induced cis-isomerrich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects," British Journal of Nutrition, vol. 98, no. 1, pp. 140-146, 2007.
76. T. Ozben, "Antioxidant supplementation on cancer risk and during cancer therapy: An update," Current Topics in Medicinal Chemistry, vol. 15, no. 2, pp. 170-178, 2015.
77. K. Radimer, B. Bindewald, J. Hughes, B. Ervin, C. Swanson, and M. F. Picciano, "Dietary supplement use byUS adults: data from the National Health and Nutrition Examination Survey, 1999-2000," The American Journal of Epidemiology, vol. 160, no. 4, pp. 339-349, 2004.
78. J. B. Penié and A. R. E. Alfonso, "Papel de la nutrición en la prevención de la enfermedad aterosclerótica. Importancia de los suplementos dietéticos: nutracéuticos," Revista Española de Cardiologá Suplementos, vol. 11, pp. 13-17, 2011.
79. R. L. Bailey, J. J. Gahche, P. E. Miller, P. R. Thomas, and J. T. Dwyer, "Why US adults use dietary supplements," JAMA Internal Medicine, vol. 173, no. 5, pp. 355-361, 2013.
80. G. Skeie, T. Braaten, A. Hjart?aker et al., "Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study," European Journal of Clinical Nutrition, vol. 63, no. 4, pp. S226-S238, 2009.
81. A. Kunwar and K. I. Priyadarsini, "Free radicals, oxidative stress and importance of antioxidants in human health," Journal of Medical and Allied Sciences, vol. 1, no. 2, pp. 53-60, 2011.
82. H.-Y. Huang, B. Caballero, S. Chang et al., "Multivitamin/mineral supplements and prevention of chronic disease: executive summary," American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 265S-268S, 2007.
83. J. W. Lee and J. M. Davis, "Future applications of antioxidants in premature infants," Current Opinion in Pediatrics, vol. 23, no. 2, pp. 161-166, 2011.
84. A. Agarwal and L. H. Sekhon, "The role of antioxidant therapy in the treatment of male infertility," Human Fertility, vol. 13, no. 4, pp. 217-225, 2010.
85. D. J. Loren,N. P. Seeram, R. N. Schulman, andD. M. Holtzman, "Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxicischemic brain injury," Pediatric Research, vol. 57,no. 6, pp. 858-864, 2005.
86. T. West, M. Atzeva, and D. M. Holtzman, "Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury," Developmental Neuroscience, vol. 29, no. 4-5, pp. 363-372, 2007.
87. T. P. A. Devasagayam, J. C. Tilak, K. K. Boloor, K. S. Sane, S. S. Ghaskadbi, and R. D. Lele, "Free radicals and antioxidants in human health: current status and future prospects," Journal of Association of Physicians of India, vol. 52, pp. 794-804, 2004.
88. A. Godic, B. Poljsak, M. Adamic, and R. Dahmane, "The role of antioxidants in skin cancer prevention and treatment," OxidativeMedicine and Cellular Longevity, vol. 2014,Article ID 860479, 6 pages, 2014.
89. M. Mushtaq and S. M. Wani, "Polyphenols and human health- a review," International Journal of Pharma and Bio Sciences, vol. 4, no. 2, pp. B338-B360, 2013.
90. N. Kandasamy and N. Ashokkumar, "Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocincadmium induced diabetic nephrotoxic rats," Toxicology and Applied Pharmacology, vol. 279, no. 2, pp. 173-185, 2014.
91. K. Maeda, M. Kuzuya, X. W. Cheng et al., "Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier," Atherosclerosis, vol. 166, no. 1, pp. 23-30, 2003.
92. Y. Miura, T. Chiba, I. Tomita et al., "Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice," Journal of Nutrition, vol. 131, no. 1, pp. 27-32, 2001.
93. M. Kaplan, T. Hayek, A. Raz et al., "Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis," Journal of Nutrition, vol. 131, no. 8, pp. 2082-2089, 2001.
94. P. Russo, I. Tedesco, M. Russo, G. L. Russo, A. Venezia, and C. Cicala, "Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation," Nutrition, Metabolism and Cardiovascular Diseases, vol. 11, no. 1, pp. 25-29, 2001.
95. A. A. A. Bertelli and D. K. Das, "Grapes, wines, resveratrol, and heart health," Journal of Cardiovascular Pharmacology, vol. 54, no. 6, pp. 468-476, 2009.
96. L. Letenneur, C. Proust-Lima, A. L. Gouge, J. F. Dartigues, and P. Barberger-Gateau, "Flavonoid intake and cognitive decline over a 10-year period," The American Journal of Epidemiology, vol. 165, no. 12, pp. 1364-1371, 2007.
97. A. Ebrahimi and H. Schluesener, "Natural polyphenols against neurodegenerative disorders: potentials and pitfalls," Ageing Research Reviews, vol. 11, no. 2, pp. 329-345, 2012.
98. A. Swaminathan and G. A. Jicha, "Nutrition and prevention of Alzheimer's dementia," Frontiers in Aging Neuroscience, vol. 6, article 282, 2014.
99. Q. Dai,A. R. Borenstein, Y. Wu, J. C. Jackson, and E. B. Larson, "Fruit and vegetable juices and Alzheimer's disease: the Kame project," American Journal of Medicine, vol. 119, no. 9, pp. 751-759, 2006.
100. V. Vingtdeux, U. Dreses-Werringloer, H. Zhao, P. Davies, and P. Marambaud, "Therapeutic potential of resveratrol in Alzheimer's disease," BMC Neuroscience, vol. 9, supplement 2, article S6, 2008.
101. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease," International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
102. M.-L. Hu, "Dietary polyphenols as antioxidants and anticancer agents: more questions than answers," Chang Gung Medical Journal, vol. 34, no. 5, pp. 449-460, 2011.
103. J. A. Baur and D. A. Sinclair, "Therapeutic potential of resveratrol: the in vivo evidence," Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493-506, 2006.
104. M. Lu, B. Yuan,M. Zeng, and J. Chen, "Antioxidant capacity and major phenolic compounds of spices commonly consumed in China," Food Research International, vol. 44, no. 2, pp. 530-536, 2011.
105. M. Athar, J. H. Back, X. Tang et al., "Resveratrol: A review of preclinical studies for human cancer prevention," Toxicology and Applied Pharmacology, vol. 224, no. 3, pp. 274-283, 2007.
106. M. Vaz-da-Silva, A. I. Loureiro, A. Falcao et al., "Effect of food on the pharmacokinetic profile of trans-resveratrol," International Journal of Clinical Pharmacology and Therapeutics, vol. 46, no. 11, pp. 564-570, 2008.
107. M. Emlia Juan, M. Pilar Vinardell, and J. M. Planas, "The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful," Journal of Nutrition, vol. 132, no. 2, pp. 257-260, 2002.
108. M. Cortés-Jofré, J.-R. Rueda, G. Corsini-Muñoz, C. Fonseca-Cortés, M. Caraballoso, and X. Bonfill Cosp, "Drugs for preventing lung cancer in healthy people," Cochrane Database of Systematic Reviews, vol. 10,Article IDCD002141, 2012.
109. J. Virtamo, P. R. Taylor, J. Kontto et al., "Effects of -tocopherol and -carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study," International Journal of Cancer, vol. 135, no. 1, pp. 178-185, 2014.
110. J. M. Lappe, D. Travers-Gustafson, K. M. Davies, R. R. Recker, and R. P. Heaney, "Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial,"TheAmerican Journal of Clinical Nutrition, vol. 85, no. 6, pp. 1586-1591, 2007.
111. Y.-L. Qiao, S. M. Dawsey, F. Kamangar et al., "Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the linxian general population nutrition intervention trial," Journal of the National Cancer Institute, vol. 101, no. 7, pp. 507-518, 2009.
112. H. Hoensch, B. Groh, L. Edler, and W. Kirch, "Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence," World Journal of Gastroenterology, vol. 14, no. 14, pp. 2187-2193, 2008.
113. G. Bobe, L. B. Sansbury, P. S. Albert et al., "Dietary flavonoids and colorectal adenoma recurrence in the polyp prevention trial," Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 6, pp. 1344-1353, 2008.
114. B. N. Singh, S. Shankar, and R. K. Srivastava, "Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications," Biochemical Pharmacology, vol. 82, no. 12, pp. 1807-1821, 2011.
115. C. S. Yang, X. Wang, G. Lu, and S. C. Picinich, "Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance," Nature Reviews Cancer, vol. 9, no. 6, pp. 429-439, 2009.
116. I. Bairati, F. Meyer, M. Gélinas et al., "Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients," Journal of Clinical Oncology, vol. 23, no. 24, pp. 5805-5813, 2005.
117. I. Bairati, F. Meyer, E. Jobin et al., "Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients," International Journal of Cancer, vol. 119, no. 9, pp. 2221-2224, 2006.
118. V. Fuchs-Tarlovsky, M. Bejarano-Rosales, G. Gutierrez-Salmean, M. A. Casillas, J. C. Lopez-Alvarenga, and G. M. Ceballos-Reyes, "Efecto de la suplementación con antioxidantes sobre el estrés oxidativo y la calidad de vida durante el tratamiento oncológico en pacientes con cáncer cérvico uterino," Nutricion Hospitalaria, vol. 26, no. 4, pp. 819-826, 2011.
119. G. Zhang, Y. Wang, Y. Zhang et al., "Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy," Current Molecular Medicine, vol. 12, no. 2, pp. 163-176, 2012.
120. M. D. C. Santos Aráujo, I. L. Farias, J. Gutierres et al., "Uncaria tomentosa-adjuvant treatment for breast cancer: clinical trial," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID676984, 8 pages, 2012.
121. Y. Al-Tonbary, M. Al-Haggar, R. El-Ashry, S. El-Dakroory, H. Azzam, and A. Fouda, "Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia," Advances in Hematology, vol. 2009, Article ID 689639, 5 pages, 2009.
122. P. Lissoni, "Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms," Pathologie Biologie, vol. 55, no. 3-4, pp. 201-204, 2007.
123. A. Sookprasert, N. P. Johns, A. Pnunmanee et al., "Melatonin in patients with cancer receiving chemotherapy: A randomized, double-blind, placebo-controlled trial," Anticancer Research, vol. 34, no. 12, pp. 7327-7337, 2014.
124. A. Khafif, S. Lev-Ari, A. Vexler et al., "Curcumin: A potential radio-enhancer in head and neck cancer," Laryngoscope, vol. 119, no. 10, pp. 2019-2026, 2009.
125. E. Lecumberri, Y. M. Dupertuis, R. Miralbell, and C. Pichard, "Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy," Clinical Nutrition, vol. 32, no. 6, pp. 894-903, 2013.
126. A. Shirazi, G. Ghobadi, and M. Ghazi-Khansari, "A radiobiological review on melatonin: A novel radioprotector," Journal of Radiation Research, vol. 48, no. 4, pp. 263-272, 2007.
127. X.-Y. Wu, A.-Y. Luo, Y.-R. Zhou, and J.-H. Ren, "N-acetylcysteine reduces oxidative stress, nuclear factor-B activity and cardiomyocyte apoptosis in heart failure," Molecular Medicine Reports, vol. 10, no. 2, pp. 615-624, 2014.
128. M. L. Heaney, J. R. Gardner, N. Karasavvas et al., "Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs," Cancer Research, vol. 68, no. 19, pp. 8031-8038, 2008.
129. C. McDonald, J. Muhlbauer, G. Perlmutter, K. Taparra, and S. A. Phelan, "Peroxiredoxin proteins protectMCF-7 breast cancer cells from doxorubicin-induced toxicity," International Journal of Oncology, vol. 45, no. 1, pp. 219-226, 2014.
130. G. Liang, A. Tang,X. Lin et al., "Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mousemodel for chemoresistant liver cancer," International Journal of Oncology, vol. 37, no. 1, pp. 111-123, 2010.
131. M. Fukui, N. Yamabe, and B. T. Zhu, "Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo," European Journal of Cancer, vol. 46, no. 10, pp. 1882-1891, 2010.
132. S. Tabaczar, A. Koceva-Chyla, J. Czepas, A. Pieniazek, J. Piasecka-Zelga, and K. Gwozdzinski, "Nitroxide pirolin reduces oxidative stress generated by doxorubicin and docetaxel in blood plasma of rats bearing mammary tumor," Journal of Physiology and Pharmacology, vol. 63, no. 2, pp. 153-163, 2012.
133. N. Li, C. Sun, B. Zhou et al., "Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer," PLoSONE, vol. 9, no. 7,Article IDe100314, 2014.
134. H. Ma, T. Das, S. Pereira et al., "Efficacy of dietary antioxidants combined with a chemotherapeutic agent on human colon cancer progression in a fluorescent orthotopic mouse model," Anticancer Research, vol. 29, no. 7, pp. 2421-2426, 2009.
135. M. Notarbartolo, P. Poma,D. Perri, L. Dusonchet, M. Cervello, and N. D'Alessandro, "Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression," Cancer Letters, vol. 224, no. 1, pp. 53-65, 2005.
136. R. Wilken, M. S. Veena, M. B. Wang, and E. S. Srivatsan, "Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma," Molecular Cancer, vol. 10, article 12, 2011.
137. Y. J. Wu, L. L. Muldoon, and E. A. Neuwelt, "The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway," Journal of Pharmacology and Experimental Therapeutics, vol. 312, no. 2, pp. 424-431, 2005.
138. D. T. Dickey, L. L. Muldoon, D. F. Kraemer, and E. A. Neuwelt, "Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model," Hearing Research, vol. 193, no. 1-2, pp. 25-30, 2004.
139. A. Atessahin, S. Yilmaz, I. Karahan, A. O. Ceribasi, and A. Karaoglu, "Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats," Toxicology, vol. 212, no. 2-3, pp. 116-123, 2005.
140. F. Meyer, P. Galan, P. Douville et al., "Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU. VI. MAX trial," International Journal of Cancer, vol. 116, no. 2, pp. 182-186, 2005.
141. S. Hercberg, S. Czernichow, and P. Galan, "Tell me what your blood -carotene level is, I will tell you what your health risk is! The viewpoint of the SUVIMAX researchers," Annals of Nutrition and Metabolism, vol. 54, no. 4, pp. 310-312, 2009.
142. P. Greenwald, D. Anderson, S. A. Nelson, and P. R. Taylor, "Clinical trials of vitamin and mineral supplements for cancer prevention," American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 314S-317S, 2007.
143. A. M. Algotar,M. S. Stratton, F. R. Ahmann et al., "Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer," Prostate, vol. 73, no. 3, pp. 328-335, 2013.
144. X. Han, J. Li, T. M. Brasky et al., "Antioxidant intake and pancreatic cancer risk: the Vitamins and Lifestyle (VITAL) Study," Cancer, vol. 119, no. 7, pp. 1314-1320, 2013.
145. G. A. Sonn, W. Aronson, and M. S. Litwin, "Impact of diet on prostate cancer: A review," Prostate Cancer and Prostatic Diseases, vol. 8, no. 4, pp. 304-310, 2005.
146. M. S. Geybels, P. A. van den Brandt, F. J. van Schooten, and B. A. J. Verhage, "Oxidative stress-related genetic variants, proand antioxidant intake and status, and advanced prostate cancer risk," Cancer Epidemiology Biomarkers and Prevention, vol. 24, no. 1, pp. 178-186, 2015.
147. N. E. Fleshner, L. Kapusta, B. Donnelly et al., "Progression from high-grade prostatic intraepithelial neoplasia to cancer: A randomized trial of combination vitamin-E, soy, and selenium," Journal of Clinical Oncology, vol. 29, no. 17, pp. 2386-2390, 2011.
148. P. Feng, T. L. Li, Z. X. Guan, R. B. Franklin, and L. C. Costello, "Effect of zinc on prostatic tumorigenicity in nude mice," Annals of theNew YorkAcademy of Sciences, vol. 1010,pp. 316-320, 2003.
149. R. G. Uzzo, P. Leavis, W. Hatch et al., "Zinc inhibits nuclear factor-B activation and sensitizes prostate cancer cells to cytotoxic agents," Clinical Cancer Research, vol. 8, no. 11, pp. 3579-3583, 2002.
150. L. C. Costello, R. B. Franklin, P. Feng, M. Tan, and O. Bagasra, "Zinc and prostate cancer: A critical scientific,medical, and public interest issue (United States)," Cancer Causes and Control, vol. 16, no. 8, pp. 901-915, 2005.
151. M. F. Leitzmann, M. J. Stampfer, K. Wu, G. A. Colditz, W. C. Willett, and E. L. Giovannucci, "Zinc supplement use and risk of prostate cancer," Journal of the National Cancer Institute, vol. 95, no. 13, pp. 1004-1007, 2003.
152. E. Ho, "Zinc deficiency, DNA damage and cancer risk," Journal of Nutritional Biochemistry, vol. 15, no. 10, pp. 572-578, 2004.
153. W. J. Verret, Y. Chen, A. Ahmed et al., "A randomized, doubleblind placebo-controlled trial evaluating the effects of vitamin E and selenium on arsenic-induced skin lesions in Bangladesh," Journal ofOccupational and EnvironmentalMedicine, vol. 47,no. 10, pp. 1026-1035, 2005.
154. V. I. Sayin, M. X. Ibrahim, E. Larsson, J. A. Nilsson, P. Lindahl, and M. O. Bergo, "Antioxidants accelerate lung cancer progression in mice," Science Translational Medicine, vol. 6, no. 221, pp. 221-ra15, 2014.
155. J. M. Matés, J. A. Segura, F. J. Alonso, and J. Márquez, "Oxidative stress in apoptosis and cancer: An update," Archives of Toxicology, vol. 86, no. 11, pp. 1649-1665, 2012.
156. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, "Oxidative stress, inflammation, and cancer: how are they linked" Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603-1616, 2010.
157. A. H. Wyllie, "'Where, O death, is thy sting' A brief review of apoptosis biology,"Molecular Neurobiology, vol. 42, no. 1, pp. 4-9, 2010.
158. T. Nguyen, P. Nioi, and C. B. Pickett, "The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress,"The Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291-13295, 2009.
159. A. A. Sablina, A. V. Budanov, G. V. Ilyinskaya, L. S. Agapova, J. E. Kravchenko, and P. M. Chumakov, "Theantioxidant function of the p53 tumor suppressor," Nature Medicine, vol. 11, no. 12, pp. 1306-1313, 2005.
160. E. Gottlieb and K. H. Vousden, "p53 regulation of metabolic pathways," Cold Spring Harbor Perspectives in Biology, vol. 2, no. 4, Article ID a001040, 2010.
161. C. Gorrini, I. S. Harris, andT. W. Mak, "Modulationof oxidative stress as an anticancer strategy," Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931-947, 2013.
162. V. Fuchs-Tarlovsky, "Role of antioxidants in cancer therapy," Nutrition, vol. 29, no. 1, pp. 15-21, 2013.
163. D. R. Spitz, E. I. Azzam, J. J. Li, and D. Gius, "Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology," Cancer and Metastasis Reviews, vol. 23, no. 3-4, pp. 311-322, 2004.
164. K. Roszkowski, D. Gackowski, R. Rozalski et al., "Small field radiotherapy of head and neck cancer patients is responsible for oxidatively damaged DNA/oxidative stress on the level of a whole organism," International Journal of Cancer, vol. 123, no. 8, pp. 1964-1967, 2008.
165. N. Suhail, N. Bilal, H. Y. Khan et al., "Effect of vitamins C and e on antioxidant status of breast-cancer patients undergoing chemotherapy," Journal of Clinical Pharmacy and Therapeutics, vol. 37, no. 1, pp. 22-26, 2012.
166. T. Masahiko, N. Tsunehiko, and K. Tsutomu, "Clinical trial of adverse effect inhibition with glucosides of vitamin C and vitamin E in radiotherapy and chemotherapy," Journal of Cancer Research andTherapeutics, vol. 1, no. 4, p. 239, 2005.
167. C. Vollbracht, B. Schneider, V. Leendert, G. Weiss, L. Auerbach, and J. Beuth, "Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study inGermany," In Vivo, vol. 25, no. 6, pp. 983-990, 2011.
168. B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers, and J. B. Blumberg, "Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy" Journal of the National Cancer Institute, vol. 100, no. 11, pp. 773-783, 2008.
169. G. C. Jagetia, "Radioprotection and radiosensitization by curcumin," Advances in Experimental Medicine and Biology, vol. 595, pp. 301-320, 2007.
170. D. Chendil, R. S. Ranga, D. Meigooni, S. Sathishkumar, and M. M. Ahmed, "Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3,"Oncogene, vol. 23,no. 8, pp. 1599-1607, 2004.
171. B. B. Aggarwal, S. Shishodia, Y. Takada et al., "Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice," Clinical Cancer Research, vol. 11, no. 20, pp. 7490-7498, 2005.
172. S. K. Sandur, A. Deorukhkar, M. K. Pandey et al., "Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-B activity," International Journal of Radiation Oncology Biology Physics, vol. 75, no. 2, pp. 534-542, 2009.
173. M. M. Yallapu, D. M. Maher, V. Sundram, M. C. Bell, M. Jaggi, and S. C. Chauhan, "Curcumin induces chemo/radiosensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth," Journal of Ovarian Research, vol. 3, no. 1, article 11, 2010.
174. C.-L. Yang, Y.-Y. Liu, Y.-G. Ma et al., "Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through janus kinase-STAT3 signalling pathway," PLoS ONE, vol. 7, no. 5,Article ID e37960, 2012.
175. Vijayalaxmi, R. J. Reiter, M. L. Meltz, and T. S. Herman, "Melatonin: possible mechanisms involved in its 'radioprotective' effect," Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 404, no. 1-2, pp. 187-189, 1998.
176. E. Carrasco, P. J. Alvarez, C. Melguizo et al., "Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo," European Journal of Medicinal Chemistry, vol. 79, pp. 1-12, 2014.
177. S. R. Hall, H. L. Blundon, M. A. Ladda et al., "Jadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species-inducing mechanism," Pharmacology Research & Perspectives, vol. 3, no. 2, 2015.
178. M. Sereno, G. Gutiérrez-Gutiérrez, C. Gómez-Raposo et al., "Oxaliplatin induced-neuropathy in digestive tumors," Critical Reviews in Oncology/Hematology, vol. 89, no. 1, pp. 166-178, 2014.
179. H. Takahashi, F. Yamaguchi, and A. Teramoto, "Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children," Child's Nervous System, vol. 21, no. 8-9, pp. 701-704, 2005.
180. J.-L. Lee, S. C. Kim, J.-H. Kim et al., "Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma," Surgery, vol. 152, no. 5, pp. 851-862, 2012.
181. J.-Y. Han, K. Park, S.-W. Kim et al., "First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung," Journal of Clinical Oncology, vol. 30, no. 10, pp. 1122-1128, 2012.
182. X. Wei, F. Su,X. Su, T. Hu, and S. Hu, "Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice," Fitoterapia, vol. 83, no. 4, pp. 636-642, 2012.
183. M. B. Azad, Y. Chen, and S. B. Gibson, "Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment," Antioxidants and Redox Signaling, vol. 11, no. 4, pp. 777-790, 2009.
184. A. Arjona-Sánchez, J. Ruiz-Rabelo, M. D. Perea et al., "Effects of capecitabine and celecoxib in experimental pancreatic cancer," Pancreatology, vol. 10, no. 5, pp. 641-647, 2010.
185. H. Pelicano,D. Carney, and P. Huang, "ROS stress in cancer cells and therapeutic implications," Drug Resistance Updates, vol. 7, no. 2, pp. 97-110, 2004.
186. J. F. SanMiguel, R. Schlag, N. K. Khuageva et al., "Bortezomib plus melphalan and prednisone for initial treatment ofmultiple myeloma,"The New England Journal ofMedicine, vol. 359, no. 9, pp. 906-917, 2008.
187. Y.-H. Ling, L. Liebes, Y. Zou, and R. Perez-Soler, "Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells," Journal of Biological Chemistry, vol. 278, no. 36, pp. 33714-33723, 2003.
188. H.-H. Zhu, D.-P. Wu, J. Jin et al., "Oral tetra-arsenic tetrasulfide formula versus intravenous arsenic trioxide as firstline treatment of acute promyelocytic leukemia: A multicenter randomized controlled trial," Journal of Clinical Oncology, vol. 31, no. 33, pp. 4215-4221, 2013.
189. J. Zhou, "Arsenic trioxide: An ancient drug revived," Chinese Medical Journal, vol. 125, no. 19, pp. 3556-3560, 2012.
190. M. S. Tallman, "What is the role of arsenic in newly diagnosed APL" Best Practice & Research: Clinical Haematology, vol. 21, no. 4, pp. 659-666, 2008.
191. F. Ravandi, E. Estey, D. Jones et al., "Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin," Journal of Clinical Oncology, vol. 27, no. 4, pp. 504-510, 2009.
192. Y. M. Chung, Y. S. Bae, and S. Y. Lee, "Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis," Free Radical Biology and Medicine, vol. 34, no. 4, pp. 434-442, 2003.
193. O. Mir, J. Alexandre, A. Tran et al., "Relationship between GSTP1 Ile 105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity," Annals of Oncology, vol. 20, no. 4, pp. 736-740, 2009.
194. A. Thorburn and A. E. Frandel, "Apoptosis and anthracycline cardiotoxicity," Molecular CancerTherapeutics, vol. 5, no. 2, pp. 197-199, 2006.
195. J. Fang, H. Nakamura, and A. K. Iyer, "Tumor-targeted induction of oxystress for cancer therapy," Journal of Drug Targeting, vol. 15, no. 7-8, pp. 475-486, 2007.
196. W. P. Tsang, S. P. Y. Chau, S. K. Kong, K. P. Fung, and T. T. Kwok, "Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis," Life Sciences, vol. 73, no. 16, pp. 2047-2058, 2003.
197. M. Sterba, O. Popelová, A. Vávrová et al., "Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection," Antioxidants and Redox Signaling, vol. 18, no. 8, pp. 899-929, 2013.
198. F. S. Carvalho, A. Burgeiro, R. Garcia, A. J. Moreno, R. A. Carvalho, and P. J. Oliveira, "Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy," Medicinal Research Reviews, vol. 34, no. 1, pp. 106-135, 2014.
199. K. A. Conklin, "Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness," Integrative Cancer Therapies, vol. 3, no. 4, pp. 294-300, 2004.
200. J. Qiao, C. Gu, W. Shang et al., "Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro," Food and Chemical Toxicology, vol. 49, no. 6, pp. 1410-1415, 2011.
201. K. Sahin, M. Tuzcu, H. Gencoglu et al., "Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatininduced nephrotoxicity in rats," Life Sciences, vol. 87, no. 7-8, pp. 240-245, 2010.
202. G. I. Harisa, "Blood viscosity as a sensitive indicator for paclitaxel induced oxidative stress in human whole blood," Saudi Pharmaceutical Journal, vol. 23, no. 1, pp. 48-54, 2015.
203. T. Hadzic, N. Aykin-Burns, Y. Zhu et al., "Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing viaH2O2-mediated oxidative stress," Free Radical Biology and Medicine, vol. 48, no. 8, pp. 1024-1033, 2010.
204. T. Mizumachi, S. Suzuki, A. Naito et al., "Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells," Oncogene, vol. 27, no. 6, pp. 831-838, 2008.
205. D. L. Morse, H. Gray, C. M. Payne, and R. J. Gillies, "Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells," Molecular Cancer Therapeutics, vol. 4, no. 10, pp. 1495-1504, 2005.
206. D. Cao, B. Qiao, Z. Ge, and Y. Yuan, "Amplification loop cascade for increasing caspase activity induced by docetaxel," Journal of Cellular Biochemistry, vol. 96, no. 4, pp. 810-820, 2005.
207. L. Yang, L. Zheng, Y. Tian et al., "C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: A mechanism study," Experimental Cell Research, vol. 332, no. 1, pp. 47-59, 2015.
208. L. Galluzzi, L. Senovilla, I. Vitale et al., "Molecular mechanisms of cisplatin resistance," Oncogene, vol. 31, no. 15, pp. 1869-1883, 2012.
209. J. Lee, D. H. Lim, S. Kim et al., "Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial," Journal of Clinical Oncology, vol. 30, no. 3, pp. 268-273, 2012.
210. J. W. Albers, V. Chaudhry, G. Cavaletti, and R. C. Donehower, "Interventions for preventing neuropathy caused by cisplatin and related compounds," The Cochrane Database of Systematic Reviews, vol. 3, Article IDCD005228, 2014.
211. A. S. Darvesha, B. B. Aggarwal, andA. Bishayee, "Curcumin and liver cancer: A review," Current Pharmaceutical Biotechnology, vol. 13, no. 1, pp. 218-228, 2012.
212. D. T. Dickey, L. L. Muldoon, N. D. Doolittle, D. R. Peterson, D. F. Kraemer, and E. A. Neuwelt, "Effect of N-acetylcysteine route of administration on chemoprotection against cisplatininduced toxicity in rat models," Cancer Chemotherapy and Pharmacology, vol. 62, no. 2, pp. 235-241, 2008.